Tecan to present at J.P. Morgan Healthcare Conference
(Thomson Reuters ONE) -
Tecan Group AG /
Tecan to present at J.P. Morgan Healthcare Conference
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, January 5, 2017 - The Tecan Group (SIX Swiss Exchange:
TECN) today announced that it will present at J.P. Morgan Healthcare Conference
on January 11, 2017.
The investor presentation by David Martyr, CEO of Tecan, will begin at 5:00 pm
PST (2:00 am CET on January 12, 2017) and will be webcast live. The webcast may
be accessed under the "Investor Relations" tab of Tecan's website www.tecan.com.
A replay of the webcast will be available after the presentation and will remain
available for 90 days.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, and forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2015, Tecan generated sales of
CHF 440 million (USD 459 million; EUR 411 million). Registered shares of Tecan
Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com
Press Release:
http://hugin.info/100384/R/2069176/777246.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 05.01.2017 - 11:45 Uhr
Sprache: Deutsch
News-ID 515936
Anzahl Zeichen: 2652
contact information:
Town:
Maennedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 271 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan to present at J.P. Morgan Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
